Mental Health Clinics in Hopkinton, MA Accepting Medicare
9 Mental Health Clinics found. Showing 1 - 9
 Starting Line Wellness, Llc Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 50 W Main St, Hopkinton, MA 01748 Phone: 508-435-1250 Fax: 508-435-2213 |
Amy Kopczynski Licsw Llc Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 16 Hearthstone Rd, Hopkinton, MA 01748 Phone: 617-304-1005 |
Check Your Compass Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 249 Wood St., Hopkinton, MA 01748 Phone: 508-353-3486 |
Thriving Connections Counseling Pllc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 339 Wood St, Hopkinton, MA 01748 Phone: 401-285-0670 |
Nexus Neuropsychological Services, Llc Clinic - Mental Health Medicare: Medicare Enrolled Practice Location: 85 Main St, Hopkinton, MA 01748 Phone: 401-529-8065 |
My Place Counseling Llc Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 4 A St, Hopkinton, MA 01748 Phone: 508-686-1338 Fax: 508-205-0331 |
Hanan Khairalla Md, Llc Clinic - Adult Mental Health Medicare: Not Enrolled in Medicare Practice Location: 6 Church St, Hopkinton, MA 01748 Phone: 781-354-1872 |
Start Line Behavioral Health, Llc Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 35 Main St Ste 8, Hopkinton, MA 01748 Phone: 774-217-4558 |
Richard J. Falzone Ph.d., P.c. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 85 Main St, Hopkinton, MA 01748 Phone: 508-497-8800 |
News Archive
Using genetic engineering techniques in pigs, scientists create new model of diabetes
The incidence of diabetes is rising worldwide. Using genetic engineering techniques in pigs, scientists at Ludwig-Maximilians-Universität in Munich have created a new model of this metabolic disorder, which recapitulates many features of the disease, and promises to contribute significantly to improvements in diagnosis and therapy.
JDRF, Amylin collaborate to support metreleptin study for type 1 diabetes
The Juvenile Diabetes Research Foundation (JDRF) and Amylin Pharmaceuticals, Inc. announced today that they entered into a research collaboration agreement to provide financial support for a clinical proof-of-concept study to investigate the effects of metreleptin, an analog of the human hormone leptin, in patients with type 1 diabetes. Researchers at The University of Texas (UT) Southwestern Medical Center will conduct the study.
VOA News reports on Syria's health crisis in midst of civil war
"The United Nations estimates the civil war raging in Syria has left more than 2.5 million people in dire need of food, water, drugs and medical supplies," VOA News reports.
FDA-approved, once-daily 24-hour aspirin now available for prevention of stroke and acute cardiac events
New Haven Pharmaceuticals, Inc. today announced the availability by prescription of DURLAZA, the first and only 24-hour, extended-release aspirin capsules (162.5mg) approved by the U.S. Food and Drug Administration (FDA) for the secondary prevention of stroke and acute cardiac events, including myocardial infarction (heart attack) in high-risk cardiovascular patients.
Co-founders of Signature Genomics recognized with Inland Northwest Catalyst Award
Signature Genomics, which performs diagnostic genetic testing of chromosome abnormalities in individuals with unexplained mental retardation and/or birth defects, today announced company co-founders Dr. Lisa G. Shaffer, Ph.D., and Dr. Bassem A. Bejjani, M.D. have received the 2009 Inland Northwest Catalyst Award for Innovators of the Year.
› Verified 4 days ago